Procyon Advisors, LLC Bio Techne Corp Transaction History

Procyon Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Procyon Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Procyon Advisors, LLC holds 3,257 shares of TECH stock, worth $223,821. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,257

Previous 3,271 0.43%

Holding current value

$223,821

Previous $234,000 11.11%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$70.96 - $82.35 $993 - $1,152	-14 Reduced 0.43%	3,257 $260,000
Q2 2024 Aug 02, 2024	BUY	$62.12 - $84.15 $2,919 - $3,955	47 Added 1.46%	3,271 $234,000
Q1 2024 Apr 15, 2024	SELL	$65.98 - $77.09 $14,911 - $17,422	-226 Reduced 6.55%	3,224 $226,000
Q4 2023 Jan 18, 2024	BUY	$52.83 - $78.22 $1,373 - $2,033	26 Added 0.76%	3,450 $266,000
Q3 2023 Oct 10, 2023	BUY	$67.52 - $89.42 $36,258 - $48,018	537 Added 18.6%	3,424 $233,000
Q2 2023 Jul 17, 2023	BUY	$73.76 - $85.98 $212,945 - $248,224	2,887 New	2,887 $235,000
Q4 2022 Jan 19, 2023	BUY	$80.67 - $352.29 $214,904 - $938,500	2,664 New	2,664 $0
Q4 2021 Jan 18, 2022	BUY	$456.15 - $525.06 $36,492 - $42,004	80 Added 13.65%	666 $345,000
Q1 2021 Apr 29, 2021	SELL	$314.62 - $411.0 $140,320 - $183,306	-446 Reduced 43.22%	586 $224,000
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $37,456 - $56,471	-202 Reduced 16.37%	1,032 $273,000
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $644 - $886	-4 Reduced 0.32%	1,234 $234,000
Q4 2019 Feb 21, 2020	BUY	$189.68 - $222.09 $234,823 - $274,947	1,238 New	1,238 $272,000

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Bio Techne Corp Transaction History